plerixafor has been researched along with Thalassemias in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, JC; Gil, S; Goncalves, KA; Izsvák, Z; Kiem, HP; Li, C; Lieber, A; Liu, Z; Pande, A; Papayannopoulou, T; Raskó, T | 1 |
1 other study(ies) available for plerixafor and Thalassemias
| Article | Year |
|---|---|
Single-dose MGTA-145/plerixafor leads to efficient mobilization and in vivo transduction of HSCs with thalassemia correction in mice.
Topics: Animals; Benzylamines; Cyclams; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Leukocytes, Mononuclear; Mice; Thalassemia | 2021 |